4d Molecular Therapeutics
(NASDAQ) FDMT
4d Molecular Therapeutics Financials at a Glance
Market Cap
$436.63M
Revenue (TTM)
$120.00K
Net Income (TTM)
$209.18M
EPS (TTM)
$-3.94
P/E Ratio
-2.17
Dividend
$0.00
Beta (Volatility)
1.29 (Average)
Dividend
$0.00
Beta (Volatility)
1.29 (Average)
Price
$8.96
Volume
731,910
Open
$9.94
Price
$8.96
Volume
731,910
Open
$9.94
Previous Close
$8.98
Daily Range
$8.56 - $9.94
52-Week Range
$2.23 - $12.34
Dividend
$0.00
Beta (Volatility)
1.29 (Average)
Price
$8.96
Volume
731,910
Open
$9.94
Previous Close
$8.98
Daily Range
$8.56 - $9.94
52-Week Range
$2.23 - $12.34
FDMT News
FDMT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 4d Molecular Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
196
CEO
David H. Kirn, MD
Headquarters
EmeryVille, CA 94608, US
FDMT Financials
Key Financial Metrics (TTM)
Gross Margin
-807%
Operating Margin
-1920%
Net Income Margin
-1743%
Return on Equity
-45%
Return on Capital
-44%
Return on Assets
-37%
Earnings Yield
-46.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$436.63M
Shares Outstanding
51.01M
Volume
731.91K
Short Interest
0.00%
Avg. Volume
812.40K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$159.55M
EBITDA
$159.55M
Operating Cash Flow
$109.08M
Capital Expenditure
$0.00
Free Cash Flow
$109.08M
Cash & ST Invst.
$402.65M
Total Debt
$21.41M
4d Molecular Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$90.00K
+2900.0%
Gross Profit
$47.15M
-1571700.0%
Gross Margin
-523.87%
N/A
Market Cap
$436.63M
N/A
Market Cap/Employee
$1.92M
N/A
Employees
227
N/A
Net Income
$56.88M
-29.7%
EBITDA
$55.62M
-12.5%
Quarterly Fundamentals
Net Cash
$381.24M
-4.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$15.82M
-16.6%
Short Term Debt
$5.59M
-0.8%
Return on Assets
-36.91%
N/A
Return on Invested Capital
-44.07%
N/A
Free Cash Flow
$27.92M
+159.6%
Operating Cash Flow
$28.55M
+162.3%